In focus
Latest feed
Lupin’s Modafinil Approval Sparks Mixed Market Reaction
The Next Big Leap: Indian Pharma's Race for the Semaglutide Jackpot
A Quiet Whisper: Indian Markets Take a Breath as Year-End Approaches
Navigating the Global Tides: How US Fed Moves, Trade Deals, and the Rupee Shape India's IT, Pharma, and Metal Stocks